Expression of cytokines in acute heart transplantation rejection
暂无分享,去创建一个
[1] Yang Chenyua. The development and observeation of allograft heart heteroptopic transplantation model in the neck in rats , 2000 .
[2] Richard N. Mitchell,et al. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. , 1999, The American journal of pathology.
[3] Gao,et al. CD40‐deficient dendritic cells producing interleukin‐10, but not interleukin‐12, induce T‐cell hyporesponsiveness in vitro and prevent acute allograft rejection , 1999, Immunology.
[4] Lepper,et al. Interleukin‐10‐induced CD8 cell proliferation , 1999, Immunology.
[5] A. Deiwick,et al. In vitro and in vivo effects of an anti-CD45 monoclonal antibody in the rat. , 1999, Transplantation proceedings.
[6] S. Donath,et al. Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[7] B. Hall,et al. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy. , 1999, Transplantation.
[8] V. Pravica,et al. Cytokine gene polymorphisms and relevance to forms of rejection. , 1999, Transplantation proceedings.
[9] M. Kobayashi,et al. Inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat. , 1999, Transplantation proceedings.
[10] S. D. De Fazio,et al. Role of graft cytokine expression in the tolerogenicity of neonatal skin allografts. , 1999, Transplantation Proceedings.
[11] J. Fung,et al. Recipient pretreatment with mammalian IL-10 prolongs mouse cardiac allograft survival by inhibition of anti-donor T cell responses. , 1999, Transplantation proceedings.
[12] R. Fisher,et al. Intragraft cytokine expression and tolerance induction in rat renal allografts. , 1999, Transplantation.
[13] J. Fung,et al. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. , 1998, Transplantation.
[14] H. Shirwan,et al. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides. , 1998, Transplantation.
[15] P. Linsley,et al. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. , 1998, Journal of immunology.
[16] T. Starzl,et al. The two-way paradigm of transplantation immunology. , 1996, Clinical immunology and immunopathology.
[17] G. Miller,et al. The expression of acidic fibroblast growth factor (heparin-binding growth factor-1) and cytokine genes in human cardiac allografts and T cells. , 1993, Transplantation.